Magdalena Bryś

2.5k total citations
105 papers, 2.0k citations indexed

About

Magdalena Bryś is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Magdalena Bryś has authored 105 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Molecular Biology, 27 papers in Oncology and 21 papers in Cancer Research. Recurrent topics in Magdalena Bryś's work include DNA Repair Mechanisms (13 papers), Genetic factors in colorectal cancer (12 papers) and BRCA gene mutations in cancer (8 papers). Magdalena Bryś is often cited by papers focused on DNA Repair Mechanisms (13 papers), Genetic factors in colorectal cancer (12 papers) and BRCA gene mutations in cancer (8 papers). Magdalena Bryś collaborates with scholars based in Poland, United States and Germany. Magdalena Bryś's co-authors include Ewa Forma, Anna Krześlak, Paweł Jóźwiak, Wanda M. Krajewska, Beata Olas, Hanna Romanowicz, Andrzej Bieńkiewicz, Katarzyna Wójcik‐Krowiranda, Katarzyna Starska and Iwona Lewy‐Trenda and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and International Journal of Molecular Sciences.

In The Last Decade

Magdalena Bryś

103 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Magdalena Bryś Poland 25 978 437 333 244 231 105 2.0k
Ewa Forma Poland 22 924 0.9× 382 0.9× 209 0.6× 221 0.9× 152 0.7× 75 1.5k
Shugo Suzuki Japan 32 1.1k 1.1× 467 1.1× 342 1.0× 269 1.1× 197 0.9× 141 2.6k
Chwen-Ming Shih Taiwan 29 971 1.0× 367 0.8× 275 0.8× 148 0.6× 166 0.7× 49 2.5k
Qian Ba China 28 945 1.0× 253 0.6× 333 1.0× 311 1.3× 211 0.9× 62 2.1k
Jiřina Hofmanová Czechia 24 859 0.9× 338 0.8× 314 0.9× 127 0.5× 181 0.8× 82 1.5k
Zheng‐Guo Cui Japan 26 945 1.0× 304 0.7× 464 1.4× 357 1.5× 123 0.5× 103 2.3k
Neelam Azad United States 26 1.3k 1.3× 392 0.9× 316 0.9× 289 1.2× 87 0.4× 54 2.4k
Aya Naiki‐Ito Japan 25 870 0.9× 279 0.6× 245 0.7× 151 0.6× 139 0.6× 99 1.7k
Douglas J. Kornbrust United States 27 1.5k 1.6× 432 1.0× 147 0.4× 206 0.8× 170 0.7× 39 2.8k
Hongbiao Huang China 37 2.3k 2.4× 579 1.3× 833 2.5× 222 0.9× 153 0.7× 101 3.5k

Countries citing papers authored by Magdalena Bryś

Since Specialization
Citations

This map shows the geographic impact of Magdalena Bryś's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Magdalena Bryś with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Magdalena Bryś more than expected).

Fields of papers citing papers by Magdalena Bryś

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Magdalena Bryś. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Magdalena Bryś. The network helps show where Magdalena Bryś may publish in the future.

Co-authorship network of co-authors of Magdalena Bryś

This figure shows the co-authorship network connecting the top 25 collaborators of Magdalena Bryś. A scholar is included among the top collaborators of Magdalena Bryś based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Magdalena Bryś. Magdalena Bryś is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gajek, Arkadiusz, Agnieszka Marczak, Jan Malý, et al.. (2025). MK-8776 and Olaparib Combination Acts Synergistically in Hepatocellular Carcinoma Cells, Demonstrating Lack of Adverse Effects on Liver Tissues in Ovarian Cancer PDX Model. International Journal of Molecular Sciences. 26(2). 834–834.
2.
Smolarz, Beata, Anna Zasowska‐Nowak, Magdalena Bryś, et al.. (2024). Analysis of Single Nucleotide Polymorphisms (SNPs) rs2234693 and rs9340799 of theESR1Gene and the Risk of Breast Cancer. In Vivo. 38(5). 2134–2143. 1 indexed citations
3.
Smolarz, Beata, et al.. (2024). Analysis of VEGF, IGF1/2 and the Long Noncoding RNA (lncRNA) H19 Expression in Polish Women with Endometriosis. International Journal of Molecular Sciences. 25(10). 5271–5271. 3 indexed citations
4.
Forma, Ewa, et al.. (2024). Menopause Hot Flashes and Molecular Mechanisms Modulated by Food-Derived Nutrients. Nutrients. 16(5). 655–655. 3 indexed citations
5.
Romanowicz, Hanna, et al.. (2022). Analysis of Long Non-Coding RNA (lncRNA) uc.38 and uc.63 Expression in Breast Carcinoma Patients. Genes. 13(4). 608–608. 1 indexed citations
6.
Smolarz, Beata, et al.. (2020). Polymorphisms in the 3′UTR Region of ESR2 and CYP19A1 Genes in Women With Endometriosis. European Journal of Obstetrics & Gynecology and Reproductive Biology. 250. 241–245. 6 indexed citations
7.
8.
Olas, Beata, et al.. (2020). Selected food colourants with antiplatelet activity as promising compounds for the prophylaxis and treatment of thrombosis. Food and Chemical Toxicology. 141. 111437–111437. 15 indexed citations
9.
Olas, Beata & Magdalena Bryś. (2020). Beer components and their beneficial effect on the hemostasis and cardiovascular diseases– truth or falsehood. Food and Chemical Toxicology. 146. 111782–111782. 15 indexed citations
10.
Starska, Katarzyna, Magdalena Bryś, Ewa Forma, et al.. (2015). The effect of metallothionein 2A core promoter region single-nucleotide polymorphism on accumulation of toxic metals in sinonasal inverted papilloma tissues. Toxicology and Applied Pharmacology. 285(3). 187–197. 9 indexed citations
11.
Smolarz, Beata, Marek Zadrożny, Dariusz Samulak, et al.. (2013). RAD51 genotype and triple-negative breast cancer (TNBC) risk in Polish women. Polish Journal of Pathology. 1(1). 39–43. 23 indexed citations
13.
Krześlak, Anna, Paweł Jóźwiak, Ewa Forma, et al.. (2012). Diagnostic value of glucose transporter 1 and 3 (GLUT1 and GLUT3) mRNA levelin postmenopausal women with urinary bladder cancer. 11(3). 178–182. 1 indexed citations
14.
Bryś, Magdalena, Agnieszka Morel, Ewa Forma, et al.. (2012). Relationship of urinary isoprostanes to prostate cancer occurence. Molecular and Cellular Biochemistry. 372(1-2). 149–153. 26 indexed citations
15.
Forma, Ewa, Anna Krześlak, Paweł Jóźwiak, et al.. (2012). Metallothionein 2A genetic polymorphisms and risk of prostate cancer in a Polish population. Cancer Genetics. 205(9). 432–435. 25 indexed citations
16.
Bryś, Magdalena, Olga Stasikowska‐Kanicka, Iwona Lewy‐Trenda, et al.. (2010). The expression of SOCS1 and TLR4-NFkappaB pathway molecules in neoplastic cells as potential biomarker for the aggressive tumor phenotype in laryngeal carcinoma.. SHILAP Revista de lepidopterología. 7 indexed citations
17.
Bryś, Magdalena, et al.. (2008). Dinucleotide repeat polymorphisms of RAD51, BRCA1, BRCA2 gene regions in breast cancer. Pathology International. 58(5). 275–281. 4 indexed citations
18.
Bryś, Magdalena, Magdalena Wójcik, Hanna Romanowicz‐Makowska, & Wanda M. Krajewska. (2002). Androgen receptor status in female breast cancer: RT-PCR and Western blot studies. Journal of Cancer Research and Clinical Oncology. 128(2). 85–90. 40 indexed citations
19.
Bryś, Magdalena, et al.. (2000). The smad pathway in TGF-β signalling. Journal of Clinical Medicine. 12(20). 3 indexed citations
20.
Piotrowski, Jerzy K., et al.. (1996). The monitoring of cadmium, zinc and copper in the kidneys and liver of humans deceased in the region of Cracow (Poland). Environmental Monitoring and Assessment. 43(3). 227–236. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026